Cargando…
Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage
One objective of modern neuroimaging is to identify markers that can aid in diagnosis, monitor disease progression, and impact long-term drug analysis. In this study, physiopathological modifications in seven subcortical structures of patients with mild cognitive impairment (MCI) due to Alzheimer’s...
Autores principales: | Eustache, Pierre, Nemmi, Federico, Saint-Aubert, Laure, Pariente, Jeremie, Péran, Patrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927932/ https://www.ncbi.nlm.nih.gov/pubmed/26836151 http://dx.doi.org/10.3233/JAD-150353 |
Ejemplares similares
-
Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013) -
White matter disruption at the prodromal stage of Alzheimer's disease: Relationships with hippocampal atrophy and episodic memory performance
por: Rémy, Florence, et al.
Publicado: (2015) -
Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019) -
Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study
por: Planton, Mélanie, et al.
Publicado: (2020) -
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo
por: Saint-Aubert, L., et al.
Publicado: (2013)